DeepValuesResearch
CompaniesInsightsMarketGurusPrinciplesBuffett ArchivePersonal FinanceBusiness NotesLatestBullish stocksNeutral stocksBearish stocksSectorsMost covered For agents & developers

ALLOHealthcare · Biotechnology

Allogene Therapeutics, Inc.

DeepValues Research covers Allogene Therapeutics (ALLO) with 1 research report since Oct 7, 2026. The latest Deep Value Intelligence report (Oct 7, 2026) ends with a Bearish stance (3.10/5). Sector: Healthcare · Biotechnology.

Latest stanceBearish3.10
Reports1since Oct 7, 2026
Latest reportEN

Research timeline

  1. Deep Value Intelligence

    Allogene Therapeutics, Inc. (ALLO) Deep Value Intelligence Report

    Bearish (3.10/5) on Allogene Therapeutics (ALLO), Oct 7, 2026. Price $1. ALLO is an early-stage biotechnology company with no demonstrated commercial…

    Bearish3.10EN35 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1
GMABGenmab A/S Biotechnology Bearish4.01 $29 1
MNKDMannKind Biotechnology Neutral2.63 $2 1
TPSTTempest Therapeutics Biotechnology Bearish2.65 $1.73 1
ADMAADMA Biologics Biotechnology Neutral3.37 $10 1
LENZLENZ Therapeutics Biotechnology Bearish3.12 $12.5 1

Charts from the latest report

Open report
Fundamentals Key MetricsFundamentals Key MetricsFundamentals Key MetricsYear Financial Metrics (Profitability)Year Financial Metrics (Health)Latest Earnings SnapshotCurrent Metrics Versus Historical AveragesThree-Scenario Buffett-Style Owner Earnings DCFFinancial SnapshotFactor ScorecardFinal Buffett Scorecard